Ledger.Open graph →
SEC Form D · Amendment · filed February 22, 2016

EFFECTOR THERAPEUTICS, INC

Offering
$56.0M
Sold
$56.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Markus T. Goebel · San Diego, CADirectorKen T. Haas · San Diego, CADirectorLaurence T. Lasky · San Diego, CADirectorStephen T. Worland, Ph.D · San Diego, CAExec · DirectorJonathan T. Root · San Diego, CADirectorSimeon T. George · San Diego, CADirectorDavid T. Maki · San Diego, CADirectorAlana T. Mcnulty · San Diego, CAExecMaha T. Katabi · San Diego, CADirectorStevan Rosenberg · Farmington Hills, MIExec · DirectorRyan M. Gee · CHICAGO, ILDirectorStephen A. Zabawa · CHICAGO, ILDirectorMichael Southworth · Palo Alto, CADirectorKriss E. Spradley · CHICAGO, ILExecErik S. Nelson · CHICAGO, ILDirectorHenry C. Hansel · CHICAGO, ILExec · DirectorRaymond T. Kish · CHICAGO, ILExec · DirectorAndrew J. Bresolin · CHICAGO, ILDirectorAmanda J. Forbes · HAMILTON, BermudaDirectorJohn G. Neal · HAMILTON, BermudaDirectorThomas J. Bladek · Easton, CTDirectorWilliam J. Duggan · Glastonbury, CTDirectorMasaki Taniguchi · Grand Cayman, Cayman IslandsDirectorMaha T. Katabi · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗